SEARCH

SEARCH BY CITATION

References

  • 1
    Ashok PW, Kidd A, Flett GM, Fitzmaurice A, Graham W, Templeton A. A randomized comparison of medical abortion and surgical vacuum aspiration at 10–13 weeks gestation. Hum Reprod 2002;17(1):9298.
  • 2
    Ashok PW, Flett GM, Templeton A. Termination of pregnancy at 9–13 weeks' amenorrhoea with mifepristone and misoprostol. Lancet 1998;352: 542543.
  • 3
    Ashok PW, Templeton A. Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases. Br J Obstet Gynaecol 1999;106: 706710.
  • 4
    RCOG Clinical Effectiveness Support Unit. The Care of Women Requesting Induced Abortion. London : RCOG Press, 2000.
  • 5
    RCOG Clinical Effectiveness Support Unit. National Audit of Induced Abortion 2000, Report of England and Wales. London : Royal College of Obstetricians and Gynaecologists, 2001.
  • 6
    World Health Organisation Task Force on Post-Ovulatory Methods of Fertility RegulationTermination of pregnancy with reduced doses of mifepristone. BMJ 1993;307: 532537.
  • 7
    World Health Organisation Task Force on Post-Ovulatory Methods of Fertility RegulationComparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. Br J Obstet Gynaecol 2000;107: 524530.
  • 8
    World Health Organization Task Force on PostMedical abortion at 57 to 63 days' gestation with a lower dose of mifepristone and gemeprost. A randomized controlled trial. Acta Obstet Gynecol Scand 2001;80: 447451.
  • 9
    Aubeny E, Peyron R, Turpin CL, et al. Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol. Int J Fertil Menopausal Stud 1995;40(Suppl 2):8591.
  • 10
    Bartley JB. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation. Hum Reprod 2001;16: 20982102.
  • 11
    El Refaey H, Templeton A. Early induction of abortion by a combination of oral mifepristone and misoprostol administered by the vaginal route. Contraception 1994;49: 111114.
  • 12
    El Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995;332: 983987.
  • 13
    Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 1998;13: 29622965.
  • 14
    SPSS Inc. Reference Guide, Version 7.5. Chicago , Illinois : SPSS, 1997.
  • 15
    Bartley J, Tong S, Everington D, Baird DT. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 2000;62: 297303.
  • 16
    Urquhart DR, Templeton AA, Shinewi F, et al. UK Multicentre Study—final results. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation. Contraception 1997;55: 15.
  • 17
    Urquhart DR, Templeton AA, Shinewi F, et al. UK Multicentre Trial. The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. Br J Obstet Gynaecol 1990;97: 480486.
  • 18
    Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338: 12411247.
  • 19
    Thong KJ, Baird DT. Induction of abortion with mifepristone and misoprostol in early pregnancy. Br J Obstet Gynaecol 1992;99: 10041007.
  • 20
    Fonseca W, Alencar AJ, Mota FS, Coelho HL. Misoprostol and congenital malformations. Lancet 1991;338: 56.
  • 21
    Westhoff C, Dasmahapatra R, Winikoff B, Clarke S. Predictors of analgesia use during supervised medical abortion. The Mifepristone Clinical Trials Group. Contraception 2000;61: 225229.